Your shopping cart is empty!
Lyme disease testing remains a complex and often controversial topic. Many diagnostic tools have low sensitivity, contributing to both misdiagnosis and under-diagnosis. Understanding your options - from clinical evaluations to lab-based and at-home Lyme disease tests - is key to accurate diagnosis and timely treatment.
Lyme disease is primarily a clinical diagnosis, based on a patient’s symptoms, medical history, and physical exam. Laboratory tests are used to support, not replace, clinical judgment.
In broad terms, tests for Lyme disease can be categorized as direct and indirect. Direct tests look for the bugs or parts of the bugs in various body tissues and fluids. Direct tests include PCR, FISH, cultures and biopsies, and antigen-capture tests. Indirect tests measure a person’s immune reaction to the bugs. Indirect tests include ELISA, IFA and Western Blots for Borrelia, and IgG and IgM antibody tests for co-infections.
Before exploring specific test types, it’s important to understand:
An ideal Lyme test would be both highly sensitive and highly specific—but such tests are rare in clinical practice.
PCR testing for Lyme disease detects the DNA of Borrelia bacteria in blood, urine, or cerebrospinal fluid. It is highly specific but not always sensitive, as Borrelia often resides in tissues rather than circulating in the blood.
This test involves growing the bacteria in a special medium from a patient’s blood sample. It is more sensitive than PCR and often more reliable than Western Blot. It also confirms infection through DNA sequencing once bacteria grow.
Biopsies involve removing small tissue samples from affected areas, such as a recurring EM rash. Although invasive, they can identify the presence of Lyme bacteria or associated nerve damage.
This test detects Borrelia antigens in urine using antibodies. Often combined with a “provocation phase” (e.g., using antibiotics beforehand), this method improves detection sensitivity by flushing bacterial remnants into the urine.
The ELISA test for Lyme disease measures IgM and IgG antibodies. While commonly used, its low sensitivity leads to false negatives, especially in early or chronic Lyme. It should always be paired with other clinical findings.
This test detects a broader immune response (IgG, IgM, IgA) and is usually used alongside Western Blot. While cross-reactivity can occur, high-quality lab testing can improve its reliability.
Western Blot evaluates the presence of specific antibodies to Borrelia burgdorferi. It is more sensitive than ELISA or IFA but can produce false negatives due to restrictive CDC criteria and variability in lab reporting.
Lyme disease testing can also be performed from the comfort of your home, offering a convenient way to screen for potential infection. Antibody-based tests detect the body’s immune response (IgM/IgG), while antigen-based tests look for fragments of the Borrelia bacteria (antigens) in bodily fluids. Both types of tests use lateral flow technology, similar to a home pregnancy test, where a blood sample is placed on a test strip and interacts with specific reagents. The result is typically indicated by a color change or a visible line on the strip.
These tests offer quick results and are ideal for early screening, especially if you’ve recently been exposed to ticks. While they provide a useful initial indication, professional lab testing and clinical evaluation are still necessary to confirm a Lyme disease diagnosis and determine the right treatment.
Looking for a trusted, convenient testing solution? Order your at-home Lyme disease test kit today from our online store. The one-step Lyme Disease test kit is affordable, accurate, and easy to use—an essential tool for early detection and peace of mind.
